• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

FDA grants IND clearance for Spinogenix’s ALS treatment trial

Quote
cafead

cafead

Administrator
Staff member
  • cafead   May 30, 2024 at 11:42: AM
via The US Food and Drug Administration (FDA) has granted clearance for Spinogenix’s investigational new drug (IND) application for the Phase I/II clinical trial of SPG302, a new therapy aimed at treating amyotrophic lateral sclerosis (ALS).

article source
 




Similar threads

cafead
FDA grants IND clearance for Find’s Phase I chronic optic neuropathy trial
Replies
0
Views
24
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA grants IND clearance for Galapagos’ non-Hodgkin lymphoma therapy trial
Replies
0
Views
8
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA grants IND clearance for TG Therapeutics’ trial of multiple sclerosis treatment
Replies
0
Views
29
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA grants IND clearance for Indapta’s multiple sclerosis treatment trial
Replies
0
Views
28
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA grants IND clearance for Allay’s trial of post-surgical pain treatment
Replies
0
Views
18
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote